Medicare Enrolled
Dr. Padma Nadella, M.D
Hematology & Oncology · Gainesville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nadella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nadella?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nadella
Dr. Padma Nadella is a hematology & oncology specialist in Gainesville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nadella performed 9,239 Medicare services across 2,176 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nadella received a total of $10,873 from 78 pharmaceutical and/or device companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nadella is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in GA
$10,873 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,239
Medicare services
Top 18% in GA for hematology & oncology
2,176
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~486 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,452 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
920 | $79 | $256 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
438 | $8 | $10 |
| Iron level test | 381 | $6 | $22 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
380 | $9 | $30 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
378 | $13 | $46 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
213 | $10 | $36 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
162 | $8 | $27 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
143 | $6 | $21 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $99 | $395 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
73 | $4 | $12 |
| Manual red blood cell count A laboratory test that manually counts the number of red blood cells in a blood sample. |
70 | $4 | $15 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
66 | $16 | $60 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
64 | $9 | $31 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
59 | $19 | $65 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
51 | $5 | $18 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
49 | $57 | $524 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
36 | $7 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $47 | $173 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
32 | $15 | $51 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
25 | $5 | $16 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
20 | $152 | $670 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $61 | $177 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
18 | $41 | $410 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
18 | $29 | $101 |
| New patient office visit, complex (60-74 min) | 16 | $139 | $496 |
| CT scan of abdomen with contrast A CT scan of the abdomen using a contrast dye to create detailed images of internal organs and structures. |
15 | $118 | $480 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $100 | $335 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
13 | $40 | $172 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,873
Total received (2018-2024)
Avg $1,553/year across 7 years
Top 28% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
467
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,321 (85.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,494 (13.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,942
2023
$1,618
2022
$1,877
2021
$3,430
2020
$1,331
2019
$330
2018
$345
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$222
PFIZER INC.
$196
ABBVIE INC.
$174
Regeneron Pharmaceuticals, Inc.
$138
Incyte Corporation
$107
AstraZeneca Pharmaceuticals LP
$98
Daiichi Sankyo Inc.
$69
Novartis Pharmaceuticals Corporation
$65
Astellas Pharma US Inc
$60
Janssen Biotech, Inc.
$51
GlaxoSmithKline, LLC.
$46
Rigel Pharmaceuticals, Inc.
$46
Stemline Therapeutics Inc.
$43
SOBI, INC
$42
Merck Sharp & Dohme LLC
$42
E.R. Squibb & Sons, L.L.C.
$36
Gilead Sciences, Inc.
$36
Ipsen Biopharmaceuticals, Inc
$33
Karyopharm Therapeutics Inc.
$29
Aveo Pharmaceuticals, Inc.
$29
TerSera Therapeutics LLC
$29
Tempus AI, Inc
$28
Adaptive Biotechnologies Corporation
$26
GENZYME CORPORATION
$25
Eisai Inc.
$25
PharmaEssentia USA Corporation
$23
Lilly USA, LLC
$22
BeiGene USA, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Regeneron Healthcare Solutions, Inc.
$20
Genentech USA, Inc.
$20
Coherus Biosciences Inc.
$19
Exelixis Inc.
$19
Alexion Pharmaceuticals, Inc.
$19
Genmab U.S., Inc.
$18
ADC Therapeutics America, Inc.
$17
Agios Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
ARRAY BIOPHARMA INC
$1
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$1,792
Celgene Corporation
$804
AstraZeneca Pharmaceuticals LP
$686
E.R. Squibb & Sons, L.L.C.
$573
Seagen Inc.
$556
GENZYME CORPORATION
$433
Daiichi Sankyo Inc.
$363
PFIZER INC.
$354
Genentech USA, Inc.
$320
Amgen Inc.
$308
GlaxoSmithKline, LLC.
$278
ABBVIE INC.
$266
Pharmacyclics LLC, An AbbVie Company
$254
Merck Sharp & Dohme Corporation
$244
Janssen Biotech, Inc.
$217
Exelixis Inc.
$185
Novartis Pharmaceuticals Corporation
$166
Pharmacyclics LLC, an AbbVie Company
$162
EISAI INC.
$149
Regeneron Pharmaceuticals, Inc.
$138
Epizyme, Inc.,
$124
Eisai Inc.
$124
JAZZ PHARMACEUTICALS INC.
$111
Rigel Pharmaceuticals, Inc.
$108
Gilead Sciences, Inc.
$107
Astellas Pharma US Inc
$107
AbbVie Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$103
ADC Therapeutics America, Inc.
$102
BeiGene USA, Inc.
$87
Merck Sharp & Dohme LLC
$79
Agios Pharmaceuticals, Inc.
$77
Ipsen Biopharmaceuticals, Inc
$76
TerSera Therapeutics LLC
$75
Alexion Pharmaceuticals, Inc.
$72
Heron Therapeutics, Inc.
$61
Stemline Therapeutics Inc.
$60
Regeneron Healthcare Solutions, Inc.
$57
Takeda Pharmaceuticals U.S.A., Inc.
$57
MorphoSys, US Inc.
$49
Karyopharm Therapeutics Inc.
$47
ARRAY BIOPHARMA INC
$45
SOBI, INC
$42
G1 Therapeutics, Inc.
$37
Lilly USA, LLC
$37
Deciphera Pharmaceuticals Inc.
$32
Coherus Biosciences Inc.
$32
Puma Biotechnology, Inc.
$30
Aveo Pharmaceuticals, Inc.
$29
Tempus AI, Inc
$28
Myriad Genetic Laboratories, Inc.
$26
ABIOMED
$26
Adaptive Biotechnologies Corporation
$26
Kite Pharma, Inc.
$25
Jazz Pharmaceuticals Inc.
$24
Mirati Therapeutics, Inc.
$23
PharmaEssentia USA Corporation
$23
Sumitomo Pharma America, Inc.
$22
Foundation Medicine, Inc.
$21
AVEO Pharmaceuticals, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
Myovant Sciences Inc.
$20
Clovis Oncology, Inc.
$19
Taiho Oncology, Inc.
$18
Genmab U.S., Inc.
$18
Dendreon Pharmaceuticals LLC
$18
Acrotech Biopharma LLC
$18
EMD Serono, Inc.
$17
Secura Bio, Inc.
$17
EUSA Pharma (US) LLC
$17
Sobi, Inc
$16
SERVIER PHARMACEUTICALS LLC
$16
Dova Pharmaceuticals
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Acrotech Biopharma Inc.
$13
Blueprint Medicines Corporation
$13
CTI BioPharma Corp.
$13
Seattle Genetics, Inc.
$12
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CERDELGA · CINVANTI · COPIKTRA · COSELA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · ENHERTU · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Impella · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PREVNAR 20 · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · Xermelo · Xospata · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
4.3
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nadella is a mixed practice specialist, with above-average Medicare volume (top 18% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nadella experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Nadella performed 5,452 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nadella receive payments from pharmaceutical companies?
Yes. Dr. Nadella received a total of $10,873 from 78 companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nadella's costs compare to other hematology & oncology specialists in Gainesville?
Dr. Nadella's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nadella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Gainesville
Browse hematology & oncology specialists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology